Daptomycin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Daptomycin Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) with status To Be Discontinued. The shortage was first posted on Jun 30, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Package NDC
- 57884-3151-1
- Dosage Form
- Injection
- Presentation
- Daptomycin, Injection, 500 mg/10 mL (NDC 57884-3151-1)
- Initial Posting
- Jun 30, 2026